BACKGROUND/AIM: Spontaneous regression (SR) of tumours is a rare phenomenon not yet fully understood. The aim of this study was to investigate immune cells infiltrating progressive and SR tumours in a Lewis rat sarcoma model. MATERIALS AND METHODS: Rats were subcutaneously inoculated with rat sarcoma R5-28 (clone C4) cells. Developing tumours were obtained on day 42 and cryosections were immunohistochemically processed for detection of immune cells. RESULTS: A high density of granulocytes was found in the necrotic areas of both progressive and SR tumours. CD4+ cells and CD8+ cells were rare and sparsely dispersed in the tumour tissue without clear difference between the two types of tumours. On the contrary, CD161+ cells were abundant and evenly distributed in SR tumours, but these cells were very rare in progressive tumours. CONCLUSION: Based on the differences in number and distribution of the immune cell subpopulations, we believe that natural killer (CD161+) cells play a major role in the destruction of cancer cells during SR of tumours in this Lewis rat model.

Department of Surgery 1st Medical Faculty of Charles University Hospital Na Bulovce Prague Czech Republic

Department of Veterinary Sciences Faculty of Agrobiology Food and Natural Resources Czech University of Life Sciences Prague Czech Republic

Institute of Animal Physiology and Genetics the Czech Academy of Sciences Libechov Czech Republic

Zobrazit více v PubMed

Ricci SB, Cerchiari U. Spontaneous regression of malignant tumors: Importance of the immune system and other factors (Review) Oncology Lett. 2010;1:941–945. PubMed PMC

Salman T. Spontaneous tumor regression. J Oncol Sci. 2016;2:1–4.

Jaganjac M, Poljak-Blazi M, Kirac I, Borovic S, Joerg Schaur R, Zarkovic N. Granulocytes as effective anticancer agent in experimental solid tumor models. Immunobiology. 2010;215:1015–1020. PubMed

Nozawa H, Chiu C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA. 2006;103:12493–12498. PubMed PMC

Treffers LW, Hiemstra IH, Kuijpers TW, van den Berg TK, Matlung HL. Neutrophils in cancer. Immunol Rev. 2016;273:312–328. PubMed

Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell. 2009;16:183–194. PubMed PMC

Mantovani A. The yin-yang of tumor-associated neutrophils. Cancer Cell. 2009;16:173–174. PubMed

Andzinski L, Kasnitz N, Stahnke S, Wu CF, Gereke M, von Kockritz-Blickwede M, Schilling B, Brandau S, Weiss S, Jablonska J. Type I IFNs induce anti-tumor polarization of tumor-associated neutrophils in mice and human. Int J Cancer. 2016;138:1982–1993. PubMed

Vesely MD, Kershaw MH, Schreiber R, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol. 2011;29:235–271. PubMed

Zhou L, Chong MMW, Littman DR. Plasticity of CD4+ T-cell lineage differentiation. Immunity. 2009;30:646–655. PubMed

Dobrzanski MJ. Expanding roles for CD4 T-cells and their subpopulations in tumor immunity and therapy. Front Oncol. 2013;3:63–63. PubMed PMC

Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G. Intratumoral T-cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003;348:203–213. PubMed

Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth A, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen Y-T, Ohtani H, Old LJ, Odunsi K. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T-cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA. 2005;102:18538–18543. PubMed PMC

Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960–1964. PubMed

Luen SJ, Savas P, Fox SB, Salgado R, Loi S. Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer. Pathology. 2017;49:141–155. PubMed

Lee N, Zakka LR, Mihm MC Jr., Schatton T. Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy. Pathology. 2016;48:177–187. PubMed

Weiss SA, Han SW, Lui K, Tchack J, Shapiro R, Berman R, Zhong J, Krogsgaard M, Osman I, Darvishian F. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma. Human Pathol. 2016;57:116–125. PubMed PMC

Morávková A, Málek O, Pokorná E, Strnádel J, Hradecký H, Horák V. Immune characterization of the Lewis rats inoculated with K2 sarcoma cell line and newly derived R5-28 malignant cells. Folia Biol. 2005;51:59–165. PubMed

Strnádel J, Kverka M, Horák V, Vannucci L, Usvald D, Hlučilová J, Plánská D, Váňa P, Reisnerová H, Jílek F. Multiplex analysis of cytokines involved in tumour growth and spontaneous regression in a rat sarcoma model. Folia Biol. 2007;53:216–219. PubMed

Holubova M, Leba M, Sedmikova M, Vannucci L, Horak V. Characterization of three newly established rat sarcoma cell clones. In Vitro Cell Dev Biol Animal. 2012;48:610–618. PubMed

Kovalská J, Mishra R, Jebavý L, Makovický P, Janda J, Plánská D, Červinková M, Horák V. Tumour progression and spontaneous regression in the Lewis rat sarcoma model. Anticancer Res. 2015;35:6539–6550. PubMed

Mishra R, Kovalska J, Janda J, Vannucci L, Rajmon R, Horak V. Tumor progression is associated with increasing CD11b+ cells and CCL2 in Lewis rat sarcoma. Anticancer Res. 2015;35:703–712. PubMed

Giorda R, Rudert WA, Vavassori C, Chambers WH, Hiserodt JC, Trucco M. NKR-P1, a signal transduction molecule on natural killer cells. Science. 1990;249:298–1300. PubMed

Takahashi T, Dejbakhsh-Jones S, Strober S. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T-cells with different functional activities. J Immunol. 2006;176:211–216. PubMed

Fergusson JR, Fleming VM, Klenerman P. CD161-expressing human T-cells. Front Immunol. 2011;2:36–36. PubMed PMC

Iliopoulou EG, Karamouzis MV, Missitzis I, Ardavanis A, Sotiriadou NN, Baxevanis CN, Rigatos G, Papamichail M, Perez SA. Increased frequency of CD4+ cells expressing CD161 in cancer patients. Clin Cancer Res. 2006;12:6901–6909. PubMed

Ryan JC, Niemi EC, Goldfien RD, Hiserodt JC, Seaman WE. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium. J Immunol. 1991;147:3244–3250. PubMed

Brissette-Storkus C, Kaufman CL, Pasewicz L, Worsey HM, Lakomy R, Ildstad ST, Chambers WH. Characterization and function of the NKR-P1dim/T-cell receptor-alpha beta+ subset of rat T-cells. J Immunol. 1994;152:388–396. PubMed

Tazzyman S, Lewis CE, Murdoch C. Neutrophils: Key mediators of tumour angiogenesis. Int J Exp Pathol. 2009;90:222–231. PubMed PMC

Watanabe K, Koizumi F, Kurashige Y, Tsurufuji S, Nakagawa H. Rat CINC, a member of the interleukin-8 family, is a neutrophil-specific chemoattractant in vivo. Exp Mol Pathol. 1991;55:30–37. PubMed

Balamayooran G, Batra S, Balamayooran T, Cai S, Jeyaseelan S. Monocyte chemoatractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection. Infect Immunol. 2011;79:2567–2577. PubMed PMC

Gaur P, Singh AK, Shukla NK, Das SN. Inter-relation of Th1, Th2, Th17 and Treg cytokines in oral cancer patients and their clinical significance. Human Immunol. 2014;75:330–337. PubMed

Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, Pages F, Galon J. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res. 2011;71:1263–1271. PubMed

Li L, Yang C, Zhao Z, Xu B, Zheng M, Zhang C, Min Z, Guo J, Rong R. Skewed T-helper (Th)1/2-and Th17/T-regulatory cell balances in patients with renal cell carcinoma. Molec Med Rep. 2015;11:947–953. PubMed PMC

Li Q, Li Q, Chen J, Liu Y, Zhao X, Tan B, Ai J, Zhang Z, Song J, Shan B. Prevalence of Th17 and Treg cells in gastric cancer patients and its correlation with clinical parameters. Oncol Rep. 2013;30:1215–1222. PubMed

Duan MC, Zhong XN, Liu GN, Wei JR. The Treg/Th17 paradigm in lung cancer. J Immunol Res. 2014;2014:730380–730380. PubMed PMC

Rezvani K, Rouce RH. The application of natural killer cell immunotherapy for treatment of cancer. Front Immunol. 2015;6:578–578. PubMed PMC